nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—Tamoxifen—pancreatic cancer	0.0859	0.133	CbGbCtD
Lomitapide—ABCB1—Gemcitabine—pancreatic cancer	0.074	0.115	CbGbCtD
Lomitapide—ABCB1—Erlotinib—pancreatic cancer	0.0731	0.113	CbGbCtD
Lomitapide—ABCB1—Irinotecan—pancreatic cancer	0.066	0.102	CbGbCtD
Lomitapide—CYP3A4—Tamoxifen—pancreatic cancer	0.0515	0.0797	CbGbCtD
Lomitapide—ABCB1—Docetaxel—pancreatic cancer	0.0483	0.0749	CbGbCtD
Lomitapide—ABCB1—Sunitinib—pancreatic cancer	0.0481	0.0745	CbGbCtD
Lomitapide—CYP3A4—Erlotinib—pancreatic cancer	0.0438	0.0678	CbGbCtD
Lomitapide—CYP3A4—Irinotecan—pancreatic cancer	0.0395	0.0612	CbGbCtD
Lomitapide—ABCB1—Doxorubicin—pancreatic cancer	0.036	0.0558	CbGbCtD
Lomitapide—CYP3A4—Docetaxel—pancreatic cancer	0.029	0.0449	CbGbCtD
Lomitapide—CYP3A4—Sunitinib—pancreatic cancer	0.0288	0.0447	CbGbCtD
Lomitapide—CYP3A4—Doxorubicin—pancreatic cancer	0.0216	0.0334	CbGbCtD
Lomitapide—Antrafenine—PTGS2—pancreatic cancer	0.00239	1	CrCbGaD
Lomitapide—Chest pain—Gemcitabine—pancreatic cancer	0.000515	0.00146	CcSEcCtD
Lomitapide—Arthralgia—Gemcitabine—pancreatic cancer	0.000515	0.00146	CcSEcCtD
Lomitapide—Myalgia—Gemcitabine—pancreatic cancer	0.000515	0.00146	CcSEcCtD
Lomitapide—Increased appetite—Epirubicin—pancreatic cancer	0.000512	0.00145	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.000511	0.00145	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000511	0.00145	CcSEcCtD
Lomitapide—Asthenia—Erlotinib—pancreatic cancer	0.00051	0.00145	CcSEcCtD
Lomitapide—Discomfort—Gemcitabine—pancreatic cancer	0.000509	0.00145	CcSEcCtD
Lomitapide—Myalgia—Fluorouracil—pancreatic cancer	0.000506	0.00144	CcSEcCtD
Lomitapide—Chest pain—Fluorouracil—pancreatic cancer	0.000506	0.00144	CcSEcCtD
Lomitapide—Infection—Irinotecan—pancreatic cancer	0.000503	0.00143	CcSEcCtD
Lomitapide—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000503	0.00143	CcSEcCtD
Lomitapide—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000503	0.00143	CcSEcCtD
Lomitapide—Discomfort—Fluorouracil—pancreatic cancer	0.0005	0.00142	CcSEcCtD
Lomitapide—Nervous system disorder—Irinotecan—pancreatic cancer	0.000497	0.00141	CcSEcCtD
Lomitapide—Diarrhoea—Tamoxifen—pancreatic cancer	0.000491	0.0014	CcSEcCtD
Lomitapide—Infection—Gemcitabine—pancreatic cancer	0.00049	0.00139	CcSEcCtD
Lomitapide—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00049	0.00139	CcSEcCtD
Lomitapide—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000487	0.00138	CcSEcCtD
Lomitapide—Body temperature increased—Sunitinib—pancreatic cancer	0.000486	0.00138	CcSEcCtD
Lomitapide—Abdominal pain—Sunitinib—pancreatic cancer	0.000486	0.00138	CcSEcCtD
Lomitapide—Diarrhoea—Erlotinib—pancreatic cancer	0.000486	0.00138	CcSEcCtD
Lomitapide—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000485	0.00138	CcSEcCtD
Lomitapide—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000484	0.00138	CcSEcCtD
Lomitapide—Urethral disorder—Docetaxel—pancreatic cancer	0.000483	0.00137	CcSEcCtD
Lomitapide—Infection—Fluorouracil—pancreatic cancer	0.000482	0.00137	CcSEcCtD
Lomitapide—Pain in extremity—Epirubicin—pancreatic cancer	0.000481	0.00137	CcSEcCtD
Lomitapide—Skin disorder—Gemcitabine—pancreatic cancer	0.000479	0.00136	CcSEcCtD
Lomitapide—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000477	0.00136	CcSEcCtD
Lomitapide—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000476	0.00135	CcSEcCtD
Lomitapide—Dizziness—Tamoxifen—pancreatic cancer	0.000475	0.00135	CcSEcCtD
Lomitapide—Increased appetite—Doxorubicin—pancreatic cancer	0.000473	0.00135	CcSEcCtD
Lomitapide—Migraine—Epirubicin—pancreatic cancer	0.000473	0.00134	CcSEcCtD
Lomitapide—Dizziness—Erlotinib—pancreatic cancer	0.00047	0.00134	CcSEcCtD
Lomitapide—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000465	0.00132	CcSEcCtD
Lomitapide—Eye disorder—Docetaxel—pancreatic cancer	0.000461	0.00131	CcSEcCtD
Lomitapide—Cardiac disorder—Docetaxel—pancreatic cancer	0.000458	0.0013	CcSEcCtD
Lomitapide—Vomiting—Tamoxifen—pancreatic cancer	0.000457	0.0013	CcSEcCtD
Lomitapide—Paraesthesia—Irinotecan—pancreatic cancer	0.000455	0.00129	CcSEcCtD
Lomitapide—Vomiting—Erlotinib—pancreatic cancer	0.000452	0.00128	CcSEcCtD
Lomitapide—Somnolence—Irinotecan—pancreatic cancer	0.000451	0.00128	CcSEcCtD
Lomitapide—Headache—Tamoxifen—pancreatic cancer	0.00045	0.00128	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00045	0.00128	CcSEcCtD
Lomitapide—Dehydration—Epirubicin—pancreatic cancer	0.000447	0.00127	CcSEcCtD
Lomitapide—Dyspepsia—Irinotecan—pancreatic cancer	0.000446	0.00127	CcSEcCtD
Lomitapide—Headache—Erlotinib—pancreatic cancer	0.000445	0.00126	CcSEcCtD
Lomitapide—Pain in extremity—Doxorubicin—pancreatic cancer	0.000445	0.00126	CcSEcCtD
Lomitapide—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000444	0.00126	CcSEcCtD
Lomitapide—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000444	0.00126	CcSEcCtD
Lomitapide—Paraesthesia—Gemcitabine—pancreatic cancer	0.000443	0.00126	CcSEcCtD
Lomitapide—Chills—Docetaxel—pancreatic cancer	0.000442	0.00126	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000442	0.00126	CcSEcCtD
Lomitapide—Asthenia—Sunitinib—pancreatic cancer	0.000441	0.00125	CcSEcCtD
Lomitapide—Dry skin—Epirubicin—pancreatic cancer	0.000441	0.00125	CcSEcCtD
Lomitapide—Decreased appetite—Irinotecan—pancreatic cancer	0.000441	0.00125	CcSEcCtD
Lomitapide—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000439	0.00125	CcSEcCtD
Lomitapide—Somnolence—Gemcitabine—pancreatic cancer	0.000439	0.00125	CcSEcCtD
Lomitapide—Migraine—Doxorubicin—pancreatic cancer	0.000438	0.00124	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000438	0.00124	CcSEcCtD
Lomitapide—Fatigue—Irinotecan—pancreatic cancer	0.000437	0.00124	CcSEcCtD
Lomitapide—Paraesthesia—Fluorouracil—pancreatic cancer	0.000436	0.00124	CcSEcCtD
Lomitapide—Constipation—Irinotecan—pancreatic cancer	0.000433	0.00123	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000433	0.00123	CcSEcCtD
Lomitapide—Somnolence—Fluorouracil—pancreatic cancer	0.000431	0.00123	CcSEcCtD
Lomitapide—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00043	0.00122	CcSEcCtD
Lomitapide—Malnutrition—Docetaxel—pancreatic cancer	0.000429	0.00122	CcSEcCtD
Lomitapide—Decreased appetite—Gemcitabine—pancreatic cancer	0.000429	0.00122	CcSEcCtD
Lomitapide—Dyspepsia—Fluorouracil—pancreatic cancer	0.000427	0.00121	CcSEcCtD
Lomitapide—Nausea—Tamoxifen—pancreatic cancer	0.000427	0.00121	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000426	0.00121	CcSEcCtD
Lomitapide—Fatigue—Gemcitabine—pancreatic cancer	0.000426	0.00121	CcSEcCtD
Lomitapide—Gastritis—Epirubicin—pancreatic cancer	0.000425	0.00121	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000424	0.0012	CcSEcCtD
Lomitapide—Constipation—Gemcitabine—pancreatic cancer	0.000422	0.0012	CcSEcCtD
Lomitapide—Nausea—Erlotinib—pancreatic cancer	0.000422	0.0012	CcSEcCtD
Lomitapide—Decreased appetite—Fluorouracil—pancreatic cancer	0.000422	0.0012	CcSEcCtD
Lomitapide—Diarrhoea—Sunitinib—pancreatic cancer	0.000421	0.0012	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000419	0.00119	CcSEcCtD
Lomitapide—Abdominal distension—Epirubicin—pancreatic cancer	0.000418	0.00119	CcSEcCtD
Lomitapide—Feeling abnormal—Irinotecan—pancreatic cancer	0.000418	0.00119	CcSEcCtD
Lomitapide—Influenza—Epirubicin—pancreatic cancer	0.000416	0.00118	CcSEcCtD
Lomitapide—Back pain—Docetaxel—pancreatic cancer	0.000415	0.00118	CcSEcCtD
Lomitapide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000414	0.00118	CcSEcCtD
Lomitapide—Dehydration—Doxorubicin—pancreatic cancer	0.000414	0.00118	CcSEcCtD
Lomitapide—Muscle spasms—Docetaxel—pancreatic cancer	0.000413	0.00117	CcSEcCtD
Lomitapide—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000411	0.00117	CcSEcCtD
Lomitapide—Dry skin—Doxorubicin—pancreatic cancer	0.000408	0.00116	CcSEcCtD
Lomitapide—Dizziness—Sunitinib—pancreatic cancer	0.000407	0.00116	CcSEcCtD
Lomitapide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000407	0.00116	CcSEcCtD
Lomitapide—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000406	0.00115	CcSEcCtD
Lomitapide—Angina pectoris—Epirubicin—pancreatic cancer	0.000405	0.00115	CcSEcCtD
Lomitapide—Body temperature increased—Irinotecan—pancreatic cancer	0.000401	0.00114	CcSEcCtD
Lomitapide—Abdominal pain—Irinotecan—pancreatic cancer	0.000401	0.00114	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000401	0.00114	CcSEcCtD
Lomitapide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.0004	0.00114	CcSEcCtD
Lomitapide—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000398	0.00113	CcSEcCtD
Lomitapide—Anaemia—Docetaxel—pancreatic cancer	0.000397	0.00113	CcSEcCtD
Lomitapide—Gastritis—Doxorubicin—pancreatic cancer	0.000394	0.00112	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000392	0.00111	CcSEcCtD
Lomitapide—Vomiting—Sunitinib—pancreatic cancer	0.000391	0.00111	CcSEcCtD
Lomitapide—Body temperature increased—Gemcitabine—pancreatic cancer	0.00039	0.00111	CcSEcCtD
Lomitapide—Abdominal distension—Doxorubicin—pancreatic cancer	0.000387	0.0011	CcSEcCtD
Lomitapide—Headache—Sunitinib—pancreatic cancer	0.000385	0.00109	CcSEcCtD
Lomitapide—Influenza—Doxorubicin—pancreatic cancer	0.000384	0.00109	CcSEcCtD
Lomitapide—Body temperature increased—Fluorouracil—pancreatic cancer	0.000384	0.00109	CcSEcCtD
Lomitapide—Palpitations—Docetaxel—pancreatic cancer	0.000379	0.00108	CcSEcCtD
Lomitapide—Weight decreased—Epirubicin—pancreatic cancer	0.000376	0.00107	CcSEcCtD
Lomitapide—Angina pectoris—Doxorubicin—pancreatic cancer	0.000375	0.00106	CcSEcCtD
Lomitapide—Infestation NOS—Epirubicin—pancreatic cancer	0.00037	0.00105	CcSEcCtD
Lomitapide—Infestation—Epirubicin—pancreatic cancer	0.00037	0.00105	CcSEcCtD
Lomitapide—Myalgia—Docetaxel—pancreatic cancer	0.000365	0.00104	CcSEcCtD
Lomitapide—Arthralgia—Docetaxel—pancreatic cancer	0.000365	0.00104	CcSEcCtD
Lomitapide—Chest pain—Docetaxel—pancreatic cancer	0.000365	0.00104	CcSEcCtD
Lomitapide—Nausea—Sunitinib—pancreatic cancer	0.000365	0.00104	CcSEcCtD
Lomitapide—Asthenia—Irinotecan—pancreatic cancer	0.000364	0.00103	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000363	0.00103	CcSEcCtD
Lomitapide—Dry mouth—Docetaxel—pancreatic cancer	0.000357	0.00102	CcSEcCtD
Lomitapide—Asthenia—Gemcitabine—pancreatic cancer	0.000354	0.00101	CcSEcCtD
Lomitapide—Haematuria—Epirubicin—pancreatic cancer	0.000353	0.001	CcSEcCtD
Lomitapide—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00035	0.000995	CcSEcCtD
Lomitapide—Infection—Docetaxel—pancreatic cancer	0.000348	0.000989	CcSEcCtD
Lomitapide—Weight decreased—Doxorubicin—pancreatic cancer	0.000348	0.000988	CcSEcCtD
Lomitapide—Sinusitis—Epirubicin—pancreatic cancer	0.000348	0.000988	CcSEcCtD
Lomitapide—Diarrhoea—Irinotecan—pancreatic cancer	0.000347	0.000985	CcSEcCtD
Lomitapide—Nervous system disorder—Docetaxel—pancreatic cancer	0.000344	0.000976	CcSEcCtD
Lomitapide—Infestation NOS—Doxorubicin—pancreatic cancer	0.000343	0.000974	CcSEcCtD
Lomitapide—Infestation—Doxorubicin—pancreatic cancer	0.000343	0.000974	CcSEcCtD
Lomitapide—Skin disorder—Docetaxel—pancreatic cancer	0.00034	0.000967	CcSEcCtD
Lomitapide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000338	0.00096	CcSEcCtD
Lomitapide—Dizziness—Irinotecan—pancreatic cancer	0.000335	0.000952	CcSEcCtD
Lomitapide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000332	0.000943	CcSEcCtD
Lomitapide—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000328	0.000933	CcSEcCtD
Lomitapide—Haematuria—Doxorubicin—pancreatic cancer	0.000327	0.000929	CcSEcCtD
Lomitapide—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000327	0.000929	CcSEcCtD
Lomitapide—Urethral disorder—Epirubicin—pancreatic cancer	0.000326	0.000926	CcSEcCtD
Lomitapide—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000324	0.000921	CcSEcCtD
Lomitapide—Vomiting—Irinotecan—pancreatic cancer	0.000322	0.000915	CcSEcCtD
Lomitapide—Sinusitis—Doxorubicin—pancreatic cancer	0.000322	0.000914	CcSEcCtD
Lomitapide—Dizziness—Fluorouracil—pancreatic cancer	0.000321	0.000912	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000319	0.000907	CcSEcCtD
Lomitapide—Headache—Irinotecan—pancreatic cancer	0.000317	0.000902	CcSEcCtD
Lomitapide—Paraesthesia—Docetaxel—pancreatic cancer	0.000315	0.000894	CcSEcCtD
Lomitapide—Vomiting—Gemcitabine—pancreatic cancer	0.000314	0.000892	CcSEcCtD
Lomitapide—Somnolence—Docetaxel—pancreatic cancer	0.000311	0.000885	CcSEcCtD
Lomitapide—Eye disorder—Epirubicin—pancreatic cancer	0.000311	0.000883	CcSEcCtD
Lomitapide—Headache—Gemcitabine—pancreatic cancer	0.000309	0.000879	CcSEcCtD
Lomitapide—Cardiac disorder—Epirubicin—pancreatic cancer	0.000309	0.000877	CcSEcCtD
Lomitapide—Vomiting—Fluorouracil—pancreatic cancer	0.000309	0.000877	CcSEcCtD
Lomitapide—Dyspepsia—Docetaxel—pancreatic cancer	0.000308	0.000876	CcSEcCtD
Lomitapide—Decreased appetite—Docetaxel—pancreatic cancer	0.000305	0.000865	CcSEcCtD
Lomitapide—Headache—Fluorouracil—pancreatic cancer	0.000304	0.000864	CcSEcCtD
Lomitapide—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000304	0.000863	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000302	0.000859	CcSEcCtD
Lomitapide—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000302	0.000859	CcSEcCtD
Lomitapide—Fatigue—Docetaxel—pancreatic cancer	0.000302	0.000858	CcSEcCtD
Lomitapide—Urethral disorder—Doxorubicin—pancreatic cancer	0.000302	0.000857	CcSEcCtD
Lomitapide—Nausea—Irinotecan—pancreatic cancer	0.000301	0.000855	CcSEcCtD
Lomitapide—Mediastinal disorder—Epirubicin—pancreatic cancer	0.0003	0.000852	CcSEcCtD
Lomitapide—Constipation—Docetaxel—pancreatic cancer	0.0003	0.000851	CcSEcCtD
Lomitapide—Chills—Epirubicin—pancreatic cancer	0.000298	0.000848	CcSEcCtD
Lomitapide—Nausea—Gemcitabine—pancreatic cancer	0.000293	0.000833	CcSEcCtD
Lomitapide—Malnutrition—Epirubicin—pancreatic cancer	0.00029	0.000823	CcSEcCtD
Lomitapide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000289	0.00082	CcSEcCtD
Lomitapide—Nausea—Fluorouracil—pancreatic cancer	0.000288	0.000819	CcSEcCtD
Lomitapide—Eye disorder—Doxorubicin—pancreatic cancer	0.000288	0.000817	CcSEcCtD
Lomitapide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000286	0.000814	CcSEcCtD
Lomitapide—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000286	0.000811	CcSEcCtD
Lomitapide—Flatulence—Epirubicin—pancreatic cancer	0.000285	0.000811	CcSEcCtD
Lomitapide—Back pain—Epirubicin—pancreatic cancer	0.00028	0.000796	CcSEcCtD
Lomitapide—Muscle spasms—Epirubicin—pancreatic cancer	0.000278	0.000791	CcSEcCtD
Lomitapide—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000277	0.000788	CcSEcCtD
Lomitapide—Abdominal pain—Docetaxel—pancreatic cancer	0.000277	0.000787	CcSEcCtD
Lomitapide—Body temperature increased—Docetaxel—pancreatic cancer	0.000277	0.000787	CcSEcCtD
Lomitapide—Chills—Doxorubicin—pancreatic cancer	0.000276	0.000784	CcSEcCtD
Lomitapide—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000269	0.000763	CcSEcCtD
Lomitapide—Malnutrition—Doxorubicin—pancreatic cancer	0.000268	0.000761	CcSEcCtD
Lomitapide—Anaemia—Epirubicin—pancreatic cancer	0.000268	0.00076	CcSEcCtD
Lomitapide—Flatulence—Doxorubicin—pancreatic cancer	0.000264	0.00075	CcSEcCtD
Lomitapide—Malaise—Epirubicin—pancreatic cancer	0.000261	0.000742	CcSEcCtD
Lomitapide—Vertigo—Epirubicin—pancreatic cancer	0.00026	0.000739	CcSEcCtD
Lomitapide—Back pain—Doxorubicin—pancreatic cancer	0.000259	0.000736	CcSEcCtD
Lomitapide—Muscle spasms—Doxorubicin—pancreatic cancer	0.000258	0.000732	CcSEcCtD
Lomitapide—Palpitations—Epirubicin—pancreatic cancer	0.000256	0.000727	CcSEcCtD
Lomitapide—Asthenia—Docetaxel—pancreatic cancer	0.000251	0.000714	CcSEcCtD
Lomitapide—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000249	0.000706	CcSEcCtD
Lomitapide—Anaemia—Doxorubicin—pancreatic cancer	0.000248	0.000703	CcSEcCtD
Lomitapide—Chest pain—Epirubicin—pancreatic cancer	0.000246	0.0007	CcSEcCtD
Lomitapide—Arthralgia—Epirubicin—pancreatic cancer	0.000246	0.0007	CcSEcCtD
Lomitapide—Myalgia—Epirubicin—pancreatic cancer	0.000246	0.0007	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000245	0.000695	CcSEcCtD
Lomitapide—Discomfort—Epirubicin—pancreatic cancer	0.000244	0.000692	CcSEcCtD
Lomitapide—Malaise—Doxorubicin—pancreatic cancer	0.000242	0.000686	CcSEcCtD
Lomitapide—Dry mouth—Epirubicin—pancreatic cancer	0.000241	0.000685	CcSEcCtD
Lomitapide—Vertigo—Doxorubicin—pancreatic cancer	0.000241	0.000684	CcSEcCtD
Lomitapide—Diarrhoea—Docetaxel—pancreatic cancer	0.00024	0.000681	CcSEcCtD
Lomitapide—Palpitations—Doxorubicin—pancreatic cancer	0.000237	0.000673	CcSEcCtD
Lomitapide—Infection—Epirubicin—pancreatic cancer	0.000235	0.000667	CcSEcCtD
Lomitapide—Nervous system disorder—Epirubicin—pancreatic cancer	0.000232	0.000658	CcSEcCtD
Lomitapide—Dizziness—Docetaxel—pancreatic cancer	0.000232	0.000658	CcSEcCtD
Lomitapide—Skin disorder—Epirubicin—pancreatic cancer	0.00023	0.000652	CcSEcCtD
Lomitapide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000228	0.000649	CcSEcCtD
Lomitapide—Chest pain—Doxorubicin—pancreatic cancer	0.000228	0.000648	CcSEcCtD
Lomitapide—Arthralgia—Doxorubicin—pancreatic cancer	0.000228	0.000648	CcSEcCtD
Lomitapide—Myalgia—Doxorubicin—pancreatic cancer	0.000228	0.000648	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000226	0.000643	CcSEcCtD
Lomitapide—Discomfort—Doxorubicin—pancreatic cancer	0.000225	0.00064	CcSEcCtD
Lomitapide—Dry mouth—Doxorubicin—pancreatic cancer	0.000223	0.000634	CcSEcCtD
Lomitapide—Vomiting—Docetaxel—pancreatic cancer	0.000223	0.000633	CcSEcCtD
Lomitapide—Headache—Docetaxel—pancreatic cancer	0.000219	0.000624	CcSEcCtD
Lomitapide—Infection—Doxorubicin—pancreatic cancer	0.000217	0.000617	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000215	0.000612	CcSEcCtD
Lomitapide—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000214	0.000609	CcSEcCtD
Lomitapide—Skin disorder—Doxorubicin—pancreatic cancer	0.000212	0.000603	CcSEcCtD
Lomitapide—Paraesthesia—Epirubicin—pancreatic cancer	0.000212	0.000603	CcSEcCtD
Lomitapide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000211	0.0006	CcSEcCtD
Lomitapide—Somnolence—Epirubicin—pancreatic cancer	0.00021	0.000597	CcSEcCtD
Lomitapide—Nausea—Docetaxel—pancreatic cancer	0.000208	0.000591	CcSEcCtD
Lomitapide—Dyspepsia—Epirubicin—pancreatic cancer	0.000208	0.000591	CcSEcCtD
Lomitapide—Decreased appetite—Epirubicin—pancreatic cancer	0.000205	0.000584	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000204	0.00058	CcSEcCtD
Lomitapide—Fatigue—Epirubicin—pancreatic cancer	0.000204	0.000579	CcSEcCtD
Lomitapide—Constipation—Epirubicin—pancreatic cancer	0.000202	0.000574	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000199	0.000566	CcSEcCtD
Lomitapide—Paraesthesia—Doxorubicin—pancreatic cancer	0.000196	0.000558	CcSEcCtD
Lomitapide—Feeling abnormal—Epirubicin—pancreatic cancer	0.000195	0.000553	CcSEcCtD
Lomitapide—Somnolence—Doxorubicin—pancreatic cancer	0.000194	0.000552	CcSEcCtD
Lomitapide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000193	0.000549	CcSEcCtD
Lomitapide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000192	0.000547	CcSEcCtD
Lomitapide—Decreased appetite—Doxorubicin—pancreatic cancer	0.00019	0.00054	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000189	0.000536	CcSEcCtD
Lomitapide—Fatigue—Doxorubicin—pancreatic cancer	0.000188	0.000536	CcSEcCtD
Lomitapide—Constipation—Doxorubicin—pancreatic cancer	0.000187	0.000531	CcSEcCtD
Lomitapide—Body temperature increased—Epirubicin—pancreatic cancer	0.000187	0.000531	CcSEcCtD
Lomitapide—Abdominal pain—Epirubicin—pancreatic cancer	0.000187	0.000531	CcSEcCtD
Lomitapide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00018	0.000512	CcSEcCtD
Lomitapide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000179	0.000508	CcSEcCtD
Lomitapide—Body temperature increased—Doxorubicin—pancreatic cancer	0.000173	0.000491	CcSEcCtD
Lomitapide—Abdominal pain—Doxorubicin—pancreatic cancer	0.000173	0.000491	CcSEcCtD
Lomitapide—Asthenia—Epirubicin—pancreatic cancer	0.00017	0.000482	CcSEcCtD
Lomitapide—Diarrhoea—Epirubicin—pancreatic cancer	0.000162	0.000459	CcSEcCtD
Lomitapide—Asthenia—Doxorubicin—pancreatic cancer	0.000157	0.000446	CcSEcCtD
Lomitapide—Dizziness—Epirubicin—pancreatic cancer	0.000156	0.000444	CcSEcCtD
Lomitapide—Vomiting—Epirubicin—pancreatic cancer	0.00015	0.000427	CcSEcCtD
Lomitapide—Diarrhoea—Doxorubicin—pancreatic cancer	0.00015	0.000425	CcSEcCtD
Lomitapide—Headache—Epirubicin—pancreatic cancer	0.000148	0.000421	CcSEcCtD
Lomitapide—Dizziness—Doxorubicin—pancreatic cancer	0.000145	0.000411	CcSEcCtD
Lomitapide—Nausea—Epirubicin—pancreatic cancer	0.00014	0.000399	CcSEcCtD
Lomitapide—Vomiting—Doxorubicin—pancreatic cancer	0.000139	0.000395	CcSEcCtD
Lomitapide—Headache—Doxorubicin—pancreatic cancer	0.000137	0.000389	CcSEcCtD
Lomitapide—Nausea—Doxorubicin—pancreatic cancer	0.00013	0.000369	CcSEcCtD
